Mergers: Big Pharma Shrinks Some

London-GlaxoSmithKline is proposing to cut more than 2,000 jobs from its worldwide workforce of 100,000 as it seeks to generate the promised savings from its merger.

Related Content:

Pharmaceutical Executive-08-01-2001

Biotech Hotbed

Decision Making at Digital Speed

Generics: Streamline and Stimulate